[1] NAFIKOV R A,SCHOONMAKER J P,KORN K T,et al.Association of polymorphisms in solute carrier family 27,isoform A6(SLC27A6) and fatty acid-binding protein-3 and fatty acid-binding protein-4(FABP3 and FABP4) with fatty acid composition of bovine milk[J].J Dairy Sci,2013,96(9):6007-6021.
[2] SYAMSUNARNO M R,ISO T,HANAOKA H,et al.A critical role of fatty acid binding protein 4 and 5(FABP4/5) in the systemic response to fasting[J].PLoS One,2013,8(11):e79386.
[3] HARDAWAY A L,PODGORSKI I.IL-1beta,RAGE and FABP4:targeting the dynamic trio in metabolic inflammation and related pathologies[J].Future Med Chem,2013,5(10):1089-1108.
[4] CHAN K H,SONG Y,HSU Y H,et al.Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative Observational Study[J].Obesity(Silver Spring),2010,18(9):1812-1820.
[5] ORDOVAS J M.Identification of a functional polymorphism at the adipose fatty acid binding protein gene(FABP4) and demonstration of its association with cardiovascular disease:a path to follow[J].Nutr Rev,2007,65(3):130-134.
[6] PARRA S,ALONSO-VILLAVERDE C,COLL B,et al.Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection[J].Atherosclerosis,2007,194(1):175-181.
[7] WANG J,TANG J,WANG B,et al.FABP4:a novel candidate gene for polycystic ovary syndrome[J].Endocrine,2009,36(3):392-396.
[8] DOI M,MIYOSHI T,HIROHATA S,et al.Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men[J].Cardiovasc Diabetol,2011,10:44.
[9] GIRONA J,ROSALES R,PLANA N,et al.FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway[J].PLoS One,2013,8(11):e81914.
[10] 刘建夏,戴玮,钱海鑫,等.腹主动脉瘤破裂7例的诊治经验[J].东南大学学报:医学版,2007,26(2):142-143.
[11] 周铁,李军.基质金属蛋白酶-2及其诱导因子在肿瘤发展中的作用[J].现代医学,2011,39(2):254-256.
[12] 商卓.基质金属蛋白酶与压力超负荷致心室重构的研究进展[J].现代医学,2010,38(3):324-327.
[13] CABRE A,BABIO N,LAZARO I,et al.FABP4 predicts atherogenic dyslipidemia development[J].Atherosclerosis,2012,222(1):229-234.
[14] AGARDH H E,FOLKERSEN L,EKSTRAND J,et al.Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis[J].J Intern Med,2011,269(2):200-210.
[15] HOLM S,UELAND T,DAHL T B,et al.Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke[J].PLoS One,2011,6(12):e28785.
[16] LEE K,SANTIBANEZ-KOREF M,POLVIKOSKI T,et al.Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture[J].Atherosclerosis,2013,226(1):74-81.
[17] PEETERS W,de KLEIJN D P,VINK A,et al.Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events[J].Eur Heart J,2011,32(14):1758-68.
[18] ZIMMERMAN A W,VEERKAMP J H.New insights into the structure and function of fatty acid-binding proteins[J].Cell Mol Life Sci,2002,59(7):1096-116.
[19] LAMOUNIER-ZEPTER V,LOOK C,ALVAREZ J,et al.Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction:a new link between obesity and heart disease[J].Circ Res,2009,105(4):326-334.
[20] HOLLOWAY G P,LALLY J,NICKERSON J G,et al.Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle[J].J Physiol,2007,582(Pt 1):393-405.
[21] ARAGONES G,FERRE R,LAZARO I,et al.Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes[J].Atherosclerosis,2010,213(1):329-331.
[22] KESSLER K,BORGES L F,HO-TIN-NOE B,et al.Angiogenesis and remodelling in human thoracic aortic aneurysms[J].Cardiovasc Res,2014,104:147-159. |